Studies on the experimental phenylketonuria in rats

Area of Science:

• Biochemistry
• Metabolic Disorders
• Animal Models

Background:

• Phenylketonuria (PKU) is a genetic disorder characterized by impaired phenylalanine metabolism.
• Understanding PKU's metabolic pathways is crucial for developing effective treatments.
• Animal models are essential for studying complex metabolic diseases like PKU.

Purpose of the Study:

• To establish and characterize a rat model mimicking human phenylketonuria (PKU).
• To investigate the metabolic alterations in rats fed a high phenylalanine (Phe) diet.
• To analyze the regulatory mechanisms of phenylalanine catabolism in experimental PKU.

Main Methods:

• Wistar albino pregnant rats were fed diets with varying phenylalanine (Phe) concentrations.
• Offspring were exposed to high Phe diets during specific developmental stages.
• Enzyme activities (Phe hydroxylase, transaminases) and metabolite levels (Phe, Tyr, PPA, PLA, HGA, o-HPAA) were analyzed.

Main Results:

• Rats exhibited suppressed liver Phe hydroxylase activity, elevated blood Phe, and urinary excretion of phenylpyruvic acid (PPA) and phenyllactic acid (PLA).
• The model showed excessive blood tyrosine (Tyr) and urinary homogentisic acid (HGA), resembling tyrosinemia alkaptonuria.
• Differences from human PKU included absent urinary o-hydroxyphenylacetic acid (o-HPAA) and variable PPA excretion.

Conclusions:

• The established rat model effectively mimics key metabolic aspects of human PKU and tyrosinemia.
• The model provides a platform for studying PKU pathogenesis and exploring therapeutic strategies.
• Analysis of enzyme activities revealed insights into the regulatory mechanisms of Phe catabolism in experimental PKU.